Literature DB >> 16718795

Low serum levels of ghrelin are associated with gallstone disease.

Nahum Mendez-Sanchez1, Guadalupe Ponciano-Rodriguez, Luisa Bermejo-Martinez, Antonio-R Villa, Norberto-C Chavez-Tapia, Daniel Zamora-Valdes, Raul Pichardo-Bahena, Blanca Barredo-Prieto, Martha-H Uribe-Ramos, Martha-H Ramos, Hector A Baptista-Gonzalez, Misael Uribe.   

Abstract

AIM: To explore the role of ghrelin in gallstone disease.
METHODS: We carried out a cross-sectional study in 150 subjects, 38 with gallstones (cases) and 112 controls. We also did a real-time PCR-RT study in twenty gallbladder samples each. Body mass index (BMI), serum insulin, ghrelin, and serum lipids were measured. Logistic regression analyses (univariate and multivariate) were conducted to estimate the probability of gallstone disease associated with serum ghrelin concentrations.
RESULTS: Cases were statistically different from controls in gender distribution (P = 0.01), age (53 vs 44 yr, P = 0.002), BMI (28 vs 25; P = 0.004), and glucose (5.26 vs 4.98 mmol/L; P = 0.05). The prevalence of ghrelin serum levels above the third tercile was lower in subjects without metabolic syndrome (P < 0.05). In a multivariate model, we found a protective effect, when ghrelin values were higher than the median value (OR = 0.27, 95%CI 0.09-0.82, P = 0.02). Twenty (20%) gallbladder specimens expressed ghrelin mRNA.
CONCLUSION: Serum ghrelin concentrations are associated with a protective effect of GD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718795      PMCID: PMC4124389          DOI: 10.3748/wjg.v12.i19.3096

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Ghrelin and the metabolic syndrome in older adults.

Authors:  Claudia Langenberg; Jaclyn Bergstrom; Gail A Laughlin; Elizabeth Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2005-10-04       Impact factor: 5.958

Review 2.  Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor.

Authors:  M Kojima; H Hosoda; H Matsuo; K Kangawa
Journal:  Trends Endocrinol Metab       Date:  2001-04       Impact factor: 12.015

3.  Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients.

Authors:  M F Stolk; K J Van Erpecum; T L Peeters; M Samsom; A J Smout; L M Akkermans; G P Vanberge-Henegouwen
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

Review 4.  The role of leptin in human obesity and disease: a review of current evidence.

Authors:  C S Mantzoros
Journal:  Ann Intern Med       Date:  1999-04-20       Impact factor: 25.391

5.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

Review 6.  Ghrelin: structure and function.

Authors:  Masayasu Kojima; Kenji Kangawa
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

7.  Metabolic syndrome as a risk factor for gallstone disease.

Authors:  Nahum Méndez-Sánchez; Norberto C Chavez-Tapia; Daniel Motola-Kuba; Karla Sanchez-Lara; Guadalupe Ponciano-Rodríguez; Héctor Baptista; Martha H Ramos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

8.  Circulating ghrelin levels are decreased in human obesity.

Authors:  M Tschöp; C Weyer; P A Tataranni; V Devanarayan; E Ravussin; M L Heiman
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

9.  Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City.

Authors:  M Hernández-Avila; I Romieu; S Parra; J Hernández-Avila; H Madrigal; W Willett
Journal:  Salud Publica Mex       Date:  1998 Mar-Apr

10.  Motilin induces gall bladder emptying and antral contractions in the fasted state in humans.

Authors:  Y C Luiking; T L Peeters; M F Stolk; V B Nieuwenhuijs; P Portincasa; I Depoortere; G P van Berge Henegouwen; L M Akkermans
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

View more
  2 in total

Review 1.  Diverse and Complementary Effects of Ghrelin and Obestatin.

Authors:  Daniel Villarreal; Geetali Pradhan; Yu Zhou; Bingzhong Xue; Yuxiang Sun
Journal:  Biomolecules       Date:  2022-03-29

Review 2.  Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis.

Authors:  Irina N Grigor'eva
Journal:  J Pers Med       Date:  2020-12-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.